Tabula Rasa HealthCare (TRHC) Scheduled to Post Quarterly Earnings on Tuesday

Tabula Rasa HealthCare (NASDAQ:TRHC) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, November 6th. Analysts expect the company to announce earnings of $0.19 per share for the quarter.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its earnings results on Tuesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.12. Tabula Rasa HealthCare had a negative net margin of 16.78% and a positive return on equity of 4.55%. The company had revenue of $48.60 million for the quarter, compared to analysts’ expectations of $46.73 million. On average, analysts expect Tabula Rasa HealthCare to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of NASDAQ TRHC traded up $0.27 during trading on Tuesday, hitting $69.01. 2,243 shares of the company were exchanged, compared to its average volume of 340,989. Tabula Rasa HealthCare has a 12-month low of $25.87 and a 12-month high of $91.16. The company has a quick ratio of 0.33, a current ratio of 0.36 and a debt-to-equity ratio of 0.11. The firm has a market cap of $1.36 billion, a PE ratio of -1,690.00, a P/E/G ratio of 5.06 and a beta of 2.85.

Several research analysts have recently commented on TRHC shares. Robert W. Baird reiterated a “buy” rating and set a $70.00 price target on shares of Tabula Rasa HealthCare in a report on Wednesday, August 8th. Zacks Investment Research lowered Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Tuesday, August 14th. Stifel Nicolaus started coverage on Tabula Rasa HealthCare in a report on Tuesday, September 11th. They set a “hold” rating and a $95.00 price target on the stock. Oppenheimer lifted their price target on Tabula Rasa HealthCare from $65.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, August 23rd. Finally, Piper Jaffray Companies lifted their price target on Tabula Rasa HealthCare to $71.00 and gave the stock an “overweight” rating in a report on Wednesday, August 8th. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Tabula Rasa HealthCare presently has an average rating of “Buy” and a consensus target price of $75.82.

In other news, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction on Wednesday, October 17th. The stock was sold at an average price of $81.01, for a total transaction of $648,080.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. In the last quarter, insiders have sold 48,000 shares of company stock worth $3,630,240. Insiders own 14.00% of the company’s stock.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Read More: How are the companies in the S&P 500 selected?

Earnings History for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply